Literature DB >> 20723071

Spectrum of gastric emptying patterns in adult patients with cyclic vomiting syndrome.

R A Hejazi1, T H Lavenbarg, R W McCallum.   

Abstract

BACKGROUND: Cyclic vomiting syndrome (CVS) in adults is a disorder characterized by recurrent and stereotypic episodes of severe nausea, vomiting and abdominal pain separated by symptom-free intervals. Both rapid and delayed gastric emptying (GE) have been observed but the reports involved small numbers of CVS patients.
METHODS: We performed a retrospective study of 92 adult patients who met Rome Ш diagnostic criteria for CVS between 2003 and 2009 at the Kansas University Medical Center. Gastric emptying was measured by a standardized scintigraphic method involving a low fat (2%) isotope labeled egg white meal of 250 Kcal, with anterior and posterior gastric imaging in the standing position obtained at 0, 1, 2, 4 h after meal ingestion. Rapid GE was defined as <50% isotope retention at 1st h and/or <30% at 2nd h and delayed GE as >10% at 4 h. KEY
RESULTS: Ninety two patients were analyzed: 47 males and 45 females mean of age 37 ± 12 years (range: 20-68 years). There were 27 patients with a personal history of migraine headache, 30 with history of marijuana use, 12 had diabetes mellitus (DM) and 10 had irritable bowel syndrome (IBS) as an accompanying diagnosis. Fifty four patients (59%) met criteria for rapid GE, 25 (27%) had normal GE and 13 (14%) had slow GE. Eighty percent of patients with co-existing IBS symptoms were identified as rapid. The subset with delayed emptying was often associated with narcotics use, DM and marijuana use (P < 0.05). CONCLUSIONS & INFERENCES: (i) In adult CVS patients, GE is generally either rapid or normal. (ii) Cyclic vomiting syndrome is an important new etiology to explain the finding of rapid GE on a radionuclide test. (iii) The small subset of CVS patients (14%) whose GE was slow were explained by the role of narcotics and/or marijuana.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20723071     DOI: 10.1111/j.1365-2982.2010.01584.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  24 in total

1.  A technical review and clinical assessment of the wireless motility capsule.

Authors:  Richard J Saad; William L Hasler
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-12

2.  Cyclic vomiting syndrome and functional vomiting in adults: association with cannabinoid use in males.

Authors:  R S Choung; G R Locke; R M Lee; C D Schleck; A R Zinsmeister; N J Talley
Journal:  Neurogastroenterol Motil       Date:  2011-09-27       Impact factor: 3.598

Review 3.  Novel Treatments for Cyclic Vomiting Syndrome: Beyond Ondansetron and Amitriptyline.

Authors:  Sanjay Bhandari; Thangam Venkatesan
Journal:  Curr Treat Options Gastroenterol       Date:  2016-12

4.  Clinical guideline: management of gastroparesis.

Authors:  Michael Camilleri; Henry P Parkman; Mehnaz A Shafi; Thomas L Abell; Lauren Gerson
Journal:  Am J Gastroenterol       Date:  2012-11-13       Impact factor: 10.864

Review 5.  Cyclic Vomiting Syndrome in Children and Adults: What Is New in 2018?

Authors:  Katja Kovacic; Manu Sood; Thangam Venkatesan
Journal:  Curr Gastroenterol Rep       Date:  2018-08-29

Review 6.  Cyclic vomiting syndrome: epidemiology, diagnosis, and treatment.

Authors:  Sanjay Bhandari; Pinky Jha; Abhishek Thakur; Abhipsa Kar; Harrison Gerdes; Thangam Venkatesan
Journal:  Clin Auton Res       Date:  2018-02-13       Impact factor: 4.435

7.  Diabetic Gastroparesis.

Authors:  Adil E Bharucha; Yogish C Kudva; David O Prichard
Journal:  Endocr Rev       Date:  2019-10-01       Impact factor: 19.871

8.  Clinical Characteristics, Comorbidities and Hospital Outcomes in Hospitalizations with Cyclic Vomiting Syndrome: A Nationwide Analysis.

Authors:  Sanjay Bhandari; Thangam Venkatesan
Journal:  Dig Dis Sci       Date:  2017-01-03       Impact factor: 3.199

Review 9.  Gastric stasis in migraineurs: etiology, characteristics, and clinical and therapeutic implications.

Authors:  Sheena K Aurora; Spyridon Papapetropoulos; Shashidhar H Kori; Archana Kedar; Thomas L Abell
Journal:  Cephalalgia       Date:  2013-03-05       Impact factor: 6.292

10.  Marijuana Use in Patients with Symptoms of Gastroparesis: Prevalence, Patient Characteristics, and Perceived Benefit.

Authors:  Henry P Parkman; Emily P Sharkey; Linda A Nguyen; Katherine P Yates; Thomas L Abell; William L Hasler; William Snape; John Clarke; Ron Schey; Kenneth L Koch; Braden Kuo; Richard W McCallum; Irene Sarosiek; Madhusudan Grover; Gianrico Farrugia; James Tonascia; Pankaj J Pasricha
Journal:  Dig Dis Sci       Date:  2019-11-22       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.